COVID infection severity in children under 5 years old before and after Omicron emergence in the US

Lindsey Wang1,2, Nathan A Berger2,3, David C Kaelber4

  • 1Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Insights

The Omicron variant caused less severe COVID-19 outcomes in children under 5 compared to the Delta variant. This study found lower rates of emergency department visits, hospitalizations, and ICU admissions for Omicron infections in young children.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Public health

Background:

  • Rising pediatric SARS-CoV-2 infections and hospitalizations post-Omicron emergence.
  • Lack of comparative data on disease severity between Omicron and Delta in US children under 5.

Approach:

  • Retrospective cohort study using electronic health records (EHR) of 79,592 children under 5 with first-time SARS-CoV-2 infection.
  • Compared clinical outcomes between Omicron-predominant and Delta-predominant periods using propensity-score matching.
  • Analyzed emergency department visits, hospitalizations, ICU admissions, and mechanical ventilation use.

Key Points:

  • Omicron infections in children under 5 showed significantly lower risks for severe outcomes compared to Delta infections.
  • Specific risk reductions observed: ED visits (RR: 0.71), hospitalizations (RR: 0.33), ICU admissions (RR: 0.32), and mechanical ventilation (RR: 0.29).
  • No significant difference in severity was found when comparing two Delta-predominant periods.

Conclusions:

  • First-time SARS-CoV-2 infections with the Omicron variant were associated with significantly less severe clinical outcomes in children under 5 compared to the Delta variant.
  • Findings are crucial for understanding pediatric COVID-19 severity and informing public health strategies for young children.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
910
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
670
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
908
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
383
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
384
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21